Evidence map›Paper›PMID 42387435›Full record

Observational studyBMC pediatrics2026

Asthma and overt stroke in children with sickle cell disease: a multicenter pediatric cohort study in French Guiana.

Gabriel Bafunyembaka, Mathieu Nacher, Chimène Maniassom, Arriel Makembi, Philbert Furero, Narcisse Elenga

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gabriel BafunyembakaDepartment of Pediatrics, Franck Joly Hospital, Western French Guiana Hospital Center, Avenue Paul Castaing, Saint-Laurent-du-Maroni, French Guiana, 97320, France. ga.bafunyembaka@chu-guyane.fr.
Mathieu NacherClinical Investigation Center, Epidemiology and Public Health, Inserm 1424/CIC, Cayenne Hospital, 3 Avenue Alexis Blaise, Cayenne, 97300, France.
Chimène ManiassomDepartment of Pediatrics, Cayenne Hospital, 3 Avenue Alexis Blaise, Cayenne, French Guiana, 97300, France.
Arriel MakembiDepartment of Internal Medicine, Franck Joly Hospital, Western French Guiana Hospital Center, Avenue Paul Castaing, Saint-Laurent-du-Maroni, French Guiana, 97320, France.
Philbert FureroDepartment of Pediatrics, Franck Joly Hospital, Western French Guiana Hospital Center, Avenue Paul Castaing, Saint-Laurent-du-Maroni, French Guiana, 97320, France.
Narcisse ElengaDepartment of Pediatrics, Cayenne Hospital, 3 Avenue Alexis Blaise, Cayenne, French Guiana, 97300, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStroke remains one of the most severe complications of sickle cell disease (SCD) in children. Although asthma is increasingly recognized as a clinical marker of SCD severity, its association with cerebrovascular complications remains insufficiently characterized. We aimed to evaluate the association between physician-documented asthma and overt stroke in children with SCD and to explore the associations of ferritin levels and continuity of care with overt stroke.

methodsWe conducted a multicenter observational cohort study including 175 children with confirmed SCD followed in three public hospitals in French Guiana between January 2012 and December 2022. Overt stroke was defined as a clinically documented neurological deficit lasting > 24 h and confirmed by brain MRI. Asthma status, ferritin levels, and continuity of care, defined as attendance at ≥ 75% of scheduled routine visits during a 12-month period, were assessed. Multivariable penalized logistic regression was used to estimate adjusted associations with overt stroke.

resultsTwenty-four children (13.7%) had a history of overt stroke. Asthma was significantly more frequent among children with stroke than among those without stroke (41.7% vs. 16.6%; unadjusted OR 3.60; 95% CI 1.44-9.02). All 175 children had complete data for the covariates included in the adjusted multivariable analysis. In multivariable analysis, asthma remained associated with higher odds of overt stroke (adjusted OR 3.05; 95% CI 1.12-8.31). Ferritin showed a non-significant trend toward higher odds of stroke (adjusted OR 1.58 per SD increase; 95% CI 0.99-2.63). Irregular continuity of care also showed a non-significant increase in the odds of stroke (adjusted OR 2.10; 95% CI 0.88-5.02). All 175 children were included in the adjusted multivariable analysis.

conclusionsPhysician-documented asthma remained associated with higher odds of overt stroke after adjustment in this multicenter pediatric SCD cohort. Ferritin levels and irregular continuity of care showed non-significant exploratory trends. These findings suggest that asthma may identify a subgroup of children with SCD requiring closer clinical assessment. Prospective studies are needed to confirm this association and clarify its clinical significance.

Indexed as

Anemia, Sickle CellAsthmaStrokeAdolescentChildChild, PreschoolCohort StudiesFemaleFerritinsFrench GuianaHumansMaleRisk FactorsFerritinsAsthmaChildrenFerritinFrench GuianaOvert strokeSickle cell disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.